The ESMO Asia Virtual Oncology Week 2021 will be held this year in place of the ESMO Asia 2021 congress, which has been postponed to 2022. The program will be composed of several virtual events and discussions on the latest advances covering important cancer types relevant to the Asia Pacific region.
Boehringer Ingelheim is dedicated to collaborating with the oncology community on a shared journey to deliver innovative treatments for patients with cancer. At the virtual event, we will be hosting a symposium on the latest treatment options for patients with advanced/metastatic NSCLC.
Industry Satellite Symposium
Expert Perspectives in Navigating the Evolving Treatment Landscape in Advanced NSCLC
Engage with our panel of esteemed medical experts—Darren Lim, Caicun Zhou, Miura Satoru, and Chen Chung-Yu—as they provide their insight on emerging treatment strategies for advanced NSCLC in Asia. The discussions will focus on topics such as strategic approaches to NSCLC, uncommon EGFR mutations, and the role of EGFR-TKI treatment in squamous NSCLC.
Boehringer Ingelheim will be hosting this symposium on Friday, November 19, 2021 at 12:00-13:30 SGT. Registration for this virtual event is complimentary; please visit the ESMO Asia Virtual Oncology Week 2021 website to access more details by following the industry sessions included in this year’s program.
Find out more about other oncology events
Click here to find out more about other oncology meetings, congresses, symposia and activities sponsored by Boehringer Ingelheim.
© 2021 Boehringer Ingelheim International GmbH. All rights reserved.
Page last updated: November 2021
Some links in this area will let you leave Boehringer Ingelheim's site and visit external websites. If not indicated otherwise in the imprint of the external website, the linked sites are not under the control of the Boehringer Ingelheim corporation and no entity of the Boehringer Ingelheim group of companies is responsible for the contents of such linked site or any link contained in such linked site, or any changes or updates to such sites. Neither is any entity of the Boehringer Ingelheim group of companies responsible for webcasting or any other form of transmission received from any linked site. These links are provided to you only as a convenience, and the inclusion of any link does not imply endorsement by the Boehringer Ingelheim group of companies of the site. In particular, Boehringer Ingelheim is not in a position to monitor the linked third party websites completely and permanently for violations of the law. Boehringer Ingelheim therefore accepts no responsibility for the accuracy or any other aspect of the information on this website. Boehringer Ingelheim is liable, if at all, only to the extent that it was aware of illegal content and it was technically possible and reasonable to prevent its use. The data protection declaration for this website does not apply to such linked websites.
Do you want to continue ?Continue